ALK and neuroblastoma: Altogether, this study identified a cytoprotective role for autophagy in Entrectinib-treated ALK-mutated neuroblastoma cells, and the authors suggest combining the pharmacological inhibition of autophagy with ALK inhibitor as a new possible approach to prevent drug resistance, and consequently reduce NB tumors recurrence and metastasis.